I27.29

Clinical Causes: Pulmonary hypertension associated with hematologic disorders such as sickle cell anemia or thalassemia Pulmonary hypertension due to metabolic disorders, including diabetes mellitus or hypothyroidism Secondary pulmonary hypertension stemming from systemic conditions like connective tissue diseases (e.g., scleroderma, lupus) Pulmonary hypertension resulting from multifactorial mechanisms where multiple health factors contribute Other systemic disorders that impact pulmonary vasculature health

Key Symptoms: Shortness of breath, especially during physical activity Fatigue or general tiredness Dizziness or episodes of fainting (syncope) Chest pain or discomfort Swelling in the legs, ankles, or abdomen (edema) Palpitations or irregular heartbeats Rapid breathing (tachypnea)

Diagnosis Path: Medical history review focusing on underlying diseases and symptoms Physical examination to detect signs of right heart strain or fluid retention Echocardiography (ultrasound of the heart) to assess pulmonary pressures and heart function Chest X-ray to evaluate lung and heart size Right heart catheterization, the definitive test for measuring pulmonary artery pressures Laboratory tests including blood counts, metabolic panels, and assessments for specific systemic or hematologic conditions Additional tests such as ventilation-perfusion scans, MRI, or CT scans may be employed if needed

Treatment Protocols: Treating the underlying disorder, such as optimizing management of hematologic or metabolic diseases Use of medications to reduce pulmonary artery pressure, including vasodilators and prostacyclins Diuretics to manage fluid retention and relieve swelling Oxygen therapy to ensure adequate oxygen levels in the blood Anticoagulation therapy if blood clot risk is elevated Lifestyle modifications like activity regulation and dietary changes Surgical or interventional procedures may be considered if other treatments are insufficient Regular monitoring to evaluate disease progression and treatment efficacy